Blood Grouping Reagents Market

Blood Grouping Reagents Market Research, 2032

Blood Grouping Reagents Market size was USD 1.21 billion in 2021 and projected to grow from USD 1.4 billion in 2023 to USD 2.9 billion by 2032, exhibiting a CAGR of 8.4% during the forecast period.

Blood Grouping Reagents are used to ascertain human antigens of blood group like ABO, Kell, MNS, and Rhesus blood group antigens). The RhD and the ABO blood group systems are the key essential blood groups in blood transfusions. Blood classes are identified by either a protein or a molecule (carbohydrate) like the ABO antigens of blood group or several other antigens on the surface of the human red blood cell.

Market Highlights

Blood Grouping Reagents Market is expected to project a CAGR of 8.4% during the forecast period, 2022-2032

Blood Grouping Reagents Market is expected to reach USD 2.9 billion, growing at a CAGR of 8.4% during the forecast period owing to the rising demand for blood group typing and blood transfusions and growing cases of emergencies like road accidents. Moreover, the mounting penetration of healthcare and associated facilities is anticipated to boost the growth of the Blood Grouping Reagents Market over the forecast period.

Blood Grouping Reagents Market Segmentation

Antibody Screening segment is expected to dominate in the forecast period

Blood Grouping Reagents Market is classified based on the Test Type into Blood Group and Phenotype, Antibody Screening, Cross-Matching Tests, Antibody Identification, Coombs Tests, and Antigen Typing. The Antibody Screening category is projected to hold major market share over the forecast period. It is widely used for recording disclosure to contagious agents, diagnosing the origin of a transfusion reaction after an organ transplant, measuring immunological status to microorganisms, and monitoring the sluggish advancement of infection or autoimmune illness.

PCR-Based and Microarray Technique segment is expected to dominate in the forecast period

Blood Grouping Reagents Market is classified based on the Technique into PCR-Based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, and Others. The PCR-Based and Microarray Technique segment is leading the market due to the variety, simplicity, and low cost of in vitro techniques for amplifying specific target RBC polymorphism areas. PCR-based assays are used to identify the antigen kind of donor RBCs for transfusion and antibody identification reagent panels.

Market Dynamics                                                 

Growth Drivers

Growing Need for Blood Transfusions is Expected to Boost the Market Growth

The need for blood transfusions from patients with thalassemia, liver and kidney illnesses, hemolytic anemia, sickle cell anemia, and hemophilia is fueling the Blood Grouping Reagents Market. Moreover, determining a pregnant woman's fetal blood type is a vital aspect of prenatal care and is commonly done using blood grouping reagents, thereby driving the market. These elements are raising the end user demand for blood-grouping tools, which is boosting the market growth.

Increasing Awareness about the Advantages of Blood Donation is Expected to Boost the Market Growth

People worldwide are becoming more and more aware of the potential advantages of blood donation. Blood donation is also recognized to improve the physical and mental health of donors by lowering stress, enhancing emotional wellbeing, reducing the risk of heart attack and heart disease, and regenerating blood cells. Owing to these considerations, more individuals are donating their blood at clinics, hospitals, and blood banks to assist patients who require transfusions live longer. Hence, the Blood Grouping Reagents Market is witnessing increasing need for items made from blood component parts, including reagents, among end users like clinics, hospitals, and blood banks.

Restraint

Concerns Regarding Inconsistent Findings May Restrain the Market Growth

Since the COVID-19 epidemic, there has been a noticeable increase in the need for blood grouping reagent examination. The sales of market firms have increased due to the increased use of serology test kits, RT-PCR kits, and blood typing kits. Despite this, a lot of concerns have been made about the unreliable findings obtained after using fast test kits. Quality has been reduced due to the pressing need for a lot of test kits quickly. This had a negative impact on the global Blood Grouping Reagents Market.

Recent Developments

• BioLegend was a top creator of antibodies and other research tools. A $5.25 billion deal was signed by PerkinElmer to buy BioLegend in July 2021, making it a key supplier of reagents and supplies for the creation of precision medicine and diagnostic tests.
• Merck KGaA made an 18 million euro investment in a novel life science lab in Switzerland in July 2020. A laboratory facility will be constructed in Buchs, Switzerland to support the expansion of the business in reference materials.

Blood Grouping Reagents Market Key Players Covered:

• Merck KGaA
• Cardinal Health
• Beckman Coulter Inc
• Bio-Rad Laboratories Inc
• Quotient Ltd.
• Tulip Diagnostics
• Diagast SAS
• Atlas Medical
• Fortress Diagnostics
• Alpha Laboratories
• BAG Diagnostics GmbH
• Haemokinesis Pty Ltd
• Aikang
• Rapid Labs Ltd
• Anamol Laboratories Pvt. Ltd.
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Blood Grouping Reagents Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The growing cases chronic illnesses, increasing aging population, and numerous surgical procedures are projected to fuel the growth of the North America Blood Grouping Reagents Market in the upcoming years. This necessitates the use of blood grouping reagents for precise blood grouping and cross-matching. Moreover, North America is renowned for its cutting-edge technology advancements and healthcare systems. The region has witnessed the implementation of point-of-care testing tools and automated blood type systems, both of which need suitable blood grouping reagents. These developments enhance precision, effectiveness, and patient outcomes.

Impact of Covid-19 on Blood Grouping Reagents Market

The entry of the coronavirus had a negative effect on numerous industries worldwide. However, a significant amount of blood grouping reagent items was needed for diagnostic purposes due to the rising number of COVID-19 patients. There is a tremendous global demand for the growing number of assay methods available to determine whether patients have the coronavirus or not. The market players were forced to develop blood grouping reagent items due to the sudden increase in diagnostic procedures.

Blood Grouping Reagents Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Blood Grouping Reagents Market Scope and Segments:

Frequently Asked Questions (FAQ):